L
LXRX
Lexicon Pharmaceuticals Inc
1.590
-0.050-3.05%After Hours: 1.590 -0.000 -0.01%19:26 04/02 EDT
OPEN/PREV CLOSE1.610/1.640
TODAY RANGE1.580-1.630
VOL2.32M
MARKET CAP673.65M
52 WEEK RANGE0.3600-1.830
AVG VOL (3M)2.93M
% TURNOVER0.55%
TURNOVER--
P/E (TTM)-11.4636
% RANGE3.05%
EPS(TTM)-0.1387
P/E(FORWARD)-8.1538
P/B5.37
BVPS0.2959
DIVIDEND--
P/S11.61
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP666.73M
SHARES OUTSTANDING423.68M
NEXT EARNINGS05/11-05/15
FREE FLOAT419.33M
LOT SIZE1
EX-DATE05/21/2015
News
Press Releases
Financial Reports
Profile
Benzinga·5d ago
Avis Budget Group, Toyota Motor And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Dow Jones·03/23 15:30
Lexicon Pharma Price Target Maintained With a $6.00/Share by HC Wainwright & Co.
Dow Jones·03/23 12:05
Novo Nordisk Begins Study of Lexicon Oral Obesity Drug
TipRanks·03/23 11:46
Lexicon, Novo Nordisk announce initiation of LX9851 study
TipRanks·03/11 12:17
Lexicon announces results from post hoc analysis on data of sotagliflozin
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.